“HeartMate 3 LVAD As Destination Therapy Can Change Concept of Advanced Heart Failure Management: A Systematic Review and Meta Analysis in Terms of Survival Benefits and Limitations”. Vascular and Endovascular Review 8, no. 16s (December 1, 2025): 79–93. Accessed August 28, 2026. https://verjournal.com/index.php/ver/article/view/1179.